Effects of Astaxanthin Supplement on Cardiovascular Health: A Systematic Review and Meta-Analysis

Indian Journal of Pharmaceutical Education and Research

  • Yongjie Liu1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Wenyue Mo2College of Life Sciences, Hainan Normal University, Haikou, Hainan, CHINA.
  • Huaqiang Ye1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Meihua Bao3Academician Workstation, Changsha Medical University, Changsha, Hunan, CHINA.
  • Zhen Long4Guilin Medical University, Guilin, Guangxi, CHINA.
  • Ruirui Kou5Zunyi Medical University, Zunyi, Guizhou, CHINA.
  • Peiyao Qiao1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Ruilong Meng1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Ruizhu Chen6Lingkou Central Hospital of Ding'an County, Ding'an, Hainan, CHINA.
  • Rui He1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Le Du1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  • Xinzheng Gao1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA., 2College of Life Sciences, Hainan Normal University, Haikou, Hainan, CHINA.

Volume 59 Issue 3 Pages 865-874

DOI: 10.5530/ijper.20256138

Abstract

Background: The objective of this study was to evaluate the effects of astaxanthin intake on the cardiovascular disease-related indicators. Materials and Methods: Fives databases, including PUBMED, CNKI, WEIPU, WAN FANG and Clinical Trials were searched up to June 30, 2023. The random-effects model was used to calculate the summary risk. A total of 17 studies were included in this meta-analysis and a total of 1101 subjects' data were included in the analysis. In all included literature studies, a randomly assigned placebo group was established as the control. In the literature included, the average intervention dose of ASTX in the experimental group was 10.14 mg/day, with an average duration of administration of 68 days. Results: The overall study did not show a significant association between Astaxanthin (ASTX) and Systolic Blood Pressure (SBP) (standardized mean difference, SMD: -0.03, 95% CI: -0.22 to 0.17, p=0.771), Diastolic Blood Pressure (DBP) (SMD: -0.16, 95% CI: -0.35 to 0.03, p=0.100), the glucose concentration (SMD: -0.12, 95% CI: -0.39 to 0.15, p=0.398) and Body Mass Index (BMI) (SMD: -0.02, 95% CI: -0.22 to 0.18, p=0.821). However, the results revealed that astaxanthin can significantly reduce total cholesterol concentration (SMD: -0.20, 95% CI: -0.37 to -0.04, p=0.000), low-density lipoprotein cholesterol concentration (LDL-C) (SMD: -0.25, 95% CI: -0.41 to -0.09, p=0.003) and triglyceride concentration (SMD: -0.17, 95% CI: -0.32 to -0.01, p=0.033). Furthermore, astaxanthin could increase the concentrations of high-density lipoprotein cholesterol (HDL-C) (SMD: 0.18, 95% CI: 0.05 to 0.32, p=0.008). Conclusion: The results of this meta-analysis indicate that astaxanthin intake can significantly improve hyperlipidemia. Further studies are needed to validate these findings and investigate the potential cardiovascular benefits of astaxanthin.

Keywords

  • Astaxanthin
  • Cardiovascular Health
  • Efficacy
  • Hyperlipidemia
  • Meta-Analysis
IJOPP

Loading…